Manar G. Helal. “Empagliflozin Attenuates Cyclophosphamide-Induced Hepatotoxicity via Targeting Nrf2/HO-1 Signaling, Oxidative Stress, and Inflammation”. World Journal of Pharmaceutical Sciences, vol. 7, no. 11, Nov. 2019, pp. 49-59, https://wjpsonline.com/index.php/wjps/article/view/empagliflozin-attenuates-cyclophosphamide-induced-hepatotoxicity.